|
|
 |
| |
|
|
Health Care Professionals
|
Since 1994, LifeCell has been a pioneer in the science of regenerative medicine. Our flagship product, AlloDerm® Regenerative Tissue Matrix, has been used successfully in more than one million grafts and implants to date. AlloDerm® Tissue Matrix and our next generation soft-tissue repair product, Strattice™ Reconstructive Tissue Matrix, are being used by an increasing number of surgeons for a range of surgical applications including hernia repair, breast reconstruction postmastectomy, breast plastic surgery (breast augmentation revisions) and other reconstructive applications.
LifeCell’s tissue matrix products are manufactured with proprietary processes that remove cells which can lead to tissue rejection and graft failure. The resulting acellular tissue matrices are strong, safe and resistant to infection. They support tissue regeneration by promoting rapid revascularization, white cell migration and cell repopulation - ultimately transforming into host tissue for a strong, natural repair.
LifeCell’s innovative technologies, have been developed through extensive research and testing. Our products allow surgeons to restore many types of tissue damaged through injury, surgery or disease - using the body’s innate regenerative power.
After more than fifteen years of successful use, LifeCell’s patented tissue matrix technology remains “first in class” - making LifeCell the leader in tissue regeneration. To learn more about our products, applications and resources available for surgeons and health care professionals, please click on the links to the left.
Before use, physicians should review all risk information and essential prescribing information which can be found in the Strattice™ Reconstructive Tissue Matrix and AlloDerm®Regenerative Tissue Matrix Instructions for Use.
|
|
|
|
|
